Cargando…
Antimicrobial Use in Pediatric Oncology and Hematology: Protocol for a Multicenter Point-Prevalence Study With Qualitative Expert Panel Assessment
BACKGROUND: Because infections are a major driver of morbidity and mortality in children with hematologic or oncologic diseases, antimicrobials are frequently prescribed in pediatric oncology practice. However, excess or inappropriate use of antimicrobials is directly linked to the emergence of anti...
Autores principales: | Papan, Cihan, Reifenrath, Katharina, Last, Katharina, Attarbaschi, Andishe, Graf, Norbert, Groll, Andreas H, Huebner, Johannes, Laws, Hans-Jürgen, Lehrnbecher, Thomas, Liese, Johannes, Martin, Luise, Tenenbaum, Tobias, Weichert, Stefan, Vieth, Simon, von Both, Ulrich, Hufnagel, Markus, Simon, Arne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253971/ https://www.ncbi.nlm.nih.gov/pubmed/35723906 http://dx.doi.org/10.2196/35774 |
Ejemplares similares
-
Antimicrobial use in pediatric oncology and hematology in Germany and Austria, 2020/2021: a cross-sectional, multi-center point-prevalence study with a multi-step qualitative adjudication process
por: Papan, Cihan, et al.
Publicado: (2023) -
Incidence and Outcome of Invasive Fungal Diseases in Children With Hematological Malignancies and/or Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Multicenter Study
por: Lehrnbecher, Thomas, et al.
Publicado: (2019) -
Management of children with fever and neutropenia: results of a survey in 51 pediatric cancer centers in Germany, Austria, and Switzerland
por: Scheler, Max, et al.
Publicado: (2020) -
A global health perspective on SARS-CoV-2—hazards, disaster and hope
por: Meyer, Sascha, et al.
Publicado: (2020) -
COVID-19: fighting the foe with Virchow
por: Papan, Cihan, et al.
Publicado: (2021)